Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer. Yesterday, June 23, 2015, 55 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $468.00 to $511,200,530.33. Highlighted Stocks Traded by Insiders: Metabolix (MBLX) - FREE Research Report Schuler Jack W, who is 10% Owner at Metabolix, bought 1.7 million shares at $3.32 on June 23, 2015. Following this transaction, the 10% Owner owned 2.2 million shares meaning that the stake was boosted by 319.66% with the 1.7 million-share transaction. Schuler Family Foundation, who is 10% Owner at Metabolix, bought 1.7 million shares at $3.32 on June 23, 2015. Following this transaction, the 10% Owner owned 9.8 million shares meaning that the stake was boosted by 20.5% with the 1.7 million-share transaction. The shares most recently traded at $4.38, up $1.06, or 24.2% since the insider transaction. Historical insider transactions for Metabolix go as follows:
4-Week # shares bought: 4.5 million
12-Week # shares bought: 4.5 million
24-Week # shares bought: 4.5 million
The average volume for Metabolix has been 29,100 shares per day over the past 30 days. Metabolix has a market cap of $101.7 million and is part of the basic materials sector and chemicals industry. Shares are up 78.21% year-to-date as of the close of trading on Thursday. Metabolix, Inc., an advanced biomaterials company, focuses on delivering sustainable solutions to the plastics industry. The company develops and commercializes technologies for the production of polymers and chemicals in microbes and plants. Currently, there are no analysts who rate Metabolix a buy, no analysts rate it a sell, and 1 rates it a hold. Exclusive Offer: Get the latest Stock Analysis on MBLX - FREETheStreet Quant Ratings rates Metabolix as a sell. Among the areas we feel are negative, one of the most important has been a generally disappointing historical performance in the stock itself. Get the full Metabolix Ratings Report from TheStreet Quant Ratings now. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.